Package 0093-7518-31

Brand: fluticasone propionate and salmeterol

Generic: fluticasone propionate and salmeterol
NDC Package

Package Facts

Identity

Package NDC 0093-7518-31
Digits Only 0093751831
Product NDC 0093-7518
Description

1 POUCH in 1 CARTON (0093-7518-31) / 1 INHALER in 1 POUCH / 60 POWDER in 1 INHALER

Marketing

Marketing Status
Marketed Since 2022-03-23
Brand fluticasone propionate and salmeterol
Generic fluticasone propionate and salmeterol
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b", "openfda": {"unii": ["6EW8Q962A5", "O2GMZ0LF5W"], "rxcui": ["896184", "896209", "896228"], "spl_set_id": ["ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (0093-7518-31)  / 1 INHALER in 1 POUCH / 60 POWDER in 1 INHALER", "package_ndc": "0093-7518-31", "marketing_start_date": "20220323"}], "brand_name": "fluticasone propionate and salmeterol", "product_id": "0093-7518_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b", "dosage_form": "POWDER", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0093-7518", "generic_name": "fluticasone propionate and salmeterol", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "fluticasone propionate and salmeterol", "active_ingredients": [{"name": "FLUTICASONE PROPIONATE", "strength": "250 ug/1"}, {"name": "SALMETEROL XINAFOATE", "strength": "50 ug/1"}], "application_number": "ANDA213948", "marketing_category": "ANDA", "marketing_start_date": "20220323", "listing_expiration_date": "20261231"}